← FDA Drug Approvals (Drugs@FDA)
LORATADINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CATALENT PHARMA · Approved 2025-02-28
Drug application
- FDA Application #
ANDA215127- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LORATADINE
- Generic name
- Loratadine
- Active ingredients
- LORATADINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- CATALENT PHARMA
- First approval
- 2025-02-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown